Anaerobic Bacteremia: The Yield of Positive Anaerobic Blood Cultures: Patient Characteristics and Potential Risk Factors : Clinical Chemistry and Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Anaerobic Bacteremia: The Yield of Positive Anaerobic Blood Cultures: Patient Characteristics and Potential Risk Factors

Takashi Saito / Kazuyoshi Senda / Shunji Takakura / Naoko Fujihara / Toyoichiro Kudo / Yoshitsugu Iinuma / Naohisa Fujita / Toshiaki Komori / Naoshi Baba / Toshinobu Horii / Kimiko Matsuoka / Mitsune Tanimoto / Satoshi Ichiyama

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 41, Issue 3, Pages 293–297, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2003.046, June 2005

Publication History

Published Online:
2005-06-01

Abstract

The anaerobic blood culture (AN) bottle is routinely used in Japan with little discussion as to its justification or validity. We retrospectively studied the AN bottle yield of obligate anaerobes and the characteristics of, and potential risk factors in, patients with anaerobic bacteremia during a 2-year period (1999–2000) at four university hospitals and one community hospital. Thirty-four of 18310 aerobic and anaerobic blood culture sets from 6215 patients taken at the university hospitals, and 35 of 2464 samples taken from 838 patients at the community hospital, yielded obligate anaerobes. Bacteroides species and Clostridium species accounted for 60% of the isolates. Fifty-seven patients from 69 blood culture sets containing anaerobes had clinically significant anaerobic bacteremia. Among these 57 patients, 24 (49%) were oncology patients, 40 (70%) had an obvious source of anaerobic infection, 15 (26%) had recent surgery and/or were in an immunosuppressed state. We concluded that the recovery rate of obligate anaerobes isolated from AN bottles was low, and the patients with anaerobic bacteremia had limited number of underlying diseases or potential risk factors for anaerobic infections. Therefore, anaerobic blood cultures may be selectively used according to the potential risk for anaerobic infections.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Koji Hosokawa, Nobuaki Shime, and Satoru Hashimoto
Journal of the Japanese Society of Intensive Care Medicine, 2012, Volume 19, Number 3, Page 417
[2]
María José González-Abad and Mercedes Alonso-Sanz
Enfermedades Infecciosas y Microbiología Clínica, 2014, Volume 32, Number 1, Page 64
[3]
Kensuke Shoji, Hisako Komuro, Yasushi Watanabe, and Isao Miyairi
Diagnostic Microbiology and Infectious Disease, 2013, Volume 76, Number 4, Page 409
[4]
[5]
Rajendra Prasad Janapatla, Jing-Jou Yan, Mei-Lin Chien, Hung-Mo Chen, Hsiu-Mei Wu, and Jiunn-Jong Wu
Journal of Microbiology, Immunology and Infection, 2010, Volume 43, Number 2, Page 126
[6]
M.C. Claros, Z.C. Claros, D.W. Hecht, D.M. Citron, E.J.C. Goldstein, J. Silva, Y. Tang-Feldman, and A.C. Rodloff
Anaerobe, 2006, Volume 12, Number 1, Page 17
[7]
Jose Manuel Ruiz-Giardin, Arturo Noguerado, Alberto Delgado-Iribarren, José Francisco Valverde-Cánovas, Carlos Aranda-Cosgaya, María Delgado-Yagüe, María del Carmen del Rey, Isabel García, Jerónimo Jaquetti, and Alejandro Pérez
Enfermedades Infecciosas y Microbiología Clínica, 2010, Volume 28, Number 7, Page 421
[8]
Hideto Suzuki, Kazumoto Murata, and Atsushi Sakamoto
Legal Medicine, 2009, Volume 11, Page S528
[9]
Jason A. Regules, Misty D. Carlson, Steven E. Wolf, and Clinton K. Murray
Burns, 2007, Volume 33, Number 5, Page 561
[10]
Pnina Ciobutaro, Michael Lishner, Avi Kilman, Moshe Maayan, Michal Hovers, and Yona Kitay - Cohen
European Journal of Internal Medicine, 2005, Volume 16, Number 7, Page 485
[11]
Hideto Suzuki, Kazumoto Murata, and Atsushi Sakamoto
Legal Medicine, 2009, Volume 11, Number 5, Page 237
[12]
Diogo C. Haussen, Francisco Yuri B. Macedo, Caroline V. Caperton, and David C. Zuckerman
Leukemia & Lymphoma, 2011, Volume 52, Number 6, Page 1137
[13]
KENTARO IWATA and MIWA TAKAHASHI
The American Journal of the Medical Sciences, 2008, Volume 336, Number 1, Page 58
[14]
L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, and Y. Glupczynski
Clinical Microbiology and Infection, 2006, Volume 12, Number 6, Page 527

Comments (0)

Please log in or register to comment.